96-7702. Self-Regulatory Organizations; Philadelphia Stock Exchange, Inc.; Order Approving Proposed Rule Change Relating to the Bid Test Exemption  

  • [Federal Register Volume 61, Number 62 (Friday, March 29, 1996)]
    [Notices]
    [Pages 14188-14189]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 96-7702]
    
    
    
    -----------------------------------------------------------------------
    
    SECURITIES AND EXCHANGE COMMISSION
    [Release No. 34-37004; File No. SR-Phlx-95-79]
    
    
    Self-Regulatory Organizations; Philadelphia Stock Exchange, Inc.; 
    Order Approving Proposed Rule Change Relating to the Bid Test Exemption
    
    March 21, 1996.
    
    I. Introduction
    
        On January 2, 1996, the Philadelphia Stock Exchange, Inc. (``Phlx'' 
    or ``Exchange'') submitted to the Securities and Exchange Commission 
    (``Commission''), pursuant to Section 19(b)(1) of the Securities 
    Exchange Act of 1934 (``Act'') \1\ and Rule 19b-4 thereunder, \2\ a 
    proposal to extend its market maker bid test exemption. The proposed 
    rule change was published for comment in the Federal Register on 
    February 7, 1996.\3\ No comments were
    
    [[Page 14189]]
    received on the proposed rule change. This order approves the proposal.
    
        \1\ 15 U.S.C. 78s (b)(1) (1988).
        \2\ 17 CFR 240.19b-4 (1994).
        \3\ See Securities Exchange Act Release No. 36784 (January 29, 
    1996), 61 FR 4694.
    ---------------------------------------------------------------------------
    
    II. Description of the Proposal
    
        The Phlx proposes to amend its Rule 1072, Reporting Requirements 
    Applicable to Short Sales in NASD/NM Securities, to permit affiliated 
    Registered Option Traders (``ROTs'') to trade for each other's accounts 
    pursuant to the market maker exemption contained therein. Rule 1072 
    establishes specific criteria exempting Phlx specialists and ROTs from 
    the National Association of Securities Dealers, Inc.'s (``NASD'') ``bid 
    test'' applicable to Nasdaq/National Market (``NM'') securities.\4\
    
        \4\ ``Bid test'' or ``short sale'' rule.
    ---------------------------------------------------------------------------
    
        In 1994, the NASD adopted a bid test rule applicable to NM 
    securities traded through Nasdaq prohibiting short sales of NM 
    securities at or below the current inside bid when that bid is below 
    the previous inside bid.\5\ An exemption from this rule exists for 
    option market makers hedging positions with the underlying securities 
    of that option; qualifying short sales are referred to as ``exempt 
    hedge transactions.'' Pursuant to this market maker exemption, the Phlx 
    adopted Rule 1072 establishing specific criteria for a short sale to 
    qualify as an ``exempt hedge transaction'' in ``designated'' NM 
    issues.\6\ Generally, option specialists may designate as exempt short 
    sales in NM securities underlying their specialist equity options, and 
    index options if at least 10% of the value of the index is comprised of 
    NM securities. A ROT only may designate as exempt short sales in NM 
    securities underlying no more than 20 of the options or index options 
    to which the ROT has been assigned.
    
        \5\ Securities Exchange Act Release No. 34277 (June 6, 1994), 59 
    FR 34885 (granting temporary approval). NASD Rules of Fair Practice, 
    Art. III, Section 48.
        \6\ Securities Exchange Act Release No. 34632 (September 2, 
    1994), 59 FR 46999. In general, an ``exempt hedge transaction'' is a 
    short sale in an NM security that is effected to hedge, and in fact 
    serves to hedge, an existing offsetting options position or an 
    offsetting options position that was created in one or more 
    transactions contemporaneous with the short sale. Phlx Rule 
    1072(c)(2)(i). The other options exchanges adopted rules similar to 
    Phlx Rule 1072. See CBOE Rule 15.10, NYSE Rule 759A, Amex Rule 957, 
    and PSE Rule 4.19. Securities Exchange Act Release No. 34632.
    ---------------------------------------------------------------------------
    
        Proposed Phlx Rule 1072(c)(2)(iii)(A) would allow a ROT to effect 
    bid test exempt short sales in a Nasdaq/NM security which that ROT has 
    not designated as qualifying for the exemption, provided that the 
    security is a designated Nasdaq/NM security of another ROT of the same 
    member organization, and further provided that such other ROT is not 
    also present or represented by a Floor Broker in the same trading crowd 
    at the time of the bid test exempt sale. The Exchange notes that this 
    amendment is similar to a CBOE provision that permits nominees of a 
    market maker organization to qualify for the exemption.\7\
    
        \7\ Securities Exchange Act Release No. 35281 (January 26, 
    1995), 60 FR 6575.
    ---------------------------------------------------------------------------
    
    III. Discussion
    
        The Commission finds that the proposed rule change is consistent 
    with the requirements of the Act and the rules and regulations 
    thereunder applicable to a national securities exchange, and, in 
    particular, the requirements of Section 6(b)(5) \8\ that the rules of 
    an exchange be designed to promote just and equitable principles of 
    trade, prevent fraudulent and manipulative acts, and, in general, 
    protect investors and the public interest. The Commission approved the 
    NASD's short sale rule on June 29, 1994,\9\ and in so doing stated that 
    the short sale rule, together with the market maker exemption, is a 
    reasonable approach to regulating short sales of Nasdaq/NM securities. 
    The Commission believes that the Exchange's proposal is consistent with 
    the NASD's bid test rule and addresses the limitations established by 
    the NASD concerning the applicability of the market maker exemption.
    
        \8\ 15 U.S.C. 78f(b)(5) (1988).
        \9\ Securities Exchange Act Release No. 34277, supra note 5.
    ---------------------------------------------------------------------------
    
        Proposed Phlx Rule 1072(c)(2)(iii)(A) will give a member 
    organization more flexibility to manage its market making obligations 
    by allowing a ROT of such organization to effect short sales of 
    securities as bid test exempt even though the ROT has not designated 
    such securities as bid test exemption eligible, Provided that the 
    securities have been designated bid test exempt eligible by another 
    nominee of the same member organization, and further provided that the 
    bid test exempt eligible ROT is not present on the trading floor. The 
    Commission believes this is a reasonable provision designed to address 
    instances where a ROT is absent from the trading floor due to illness, 
    or personal or other business. The Commission further believes that 
    this provision is consistent with the intent of the market maker 
    exemption to the short sale rule, in that the exemption continues to be 
    limited to those Nasdaq/NM securities which are used to hedge options 
    transactions in the primary classes in which the member organization 
    makes markets.
    
    IV. Conclusion
    
        It is therefore ordered, pursuant to Section 19(b)(2) of the 
    Act,\10\ that the proposed rule change (SR-Phlx-95-79) is approved.
    
        \10\ 15 U.S.C. 78s(b)(2) (1988).
    ---------------------------------------------------------------------------
    
        For the Commission, by the Division of Market Regulation, 
    pursuant to delegated authority.\11\
    
        \11\ 17 CFR 200.30-3(a)(12) (1993).
    ---------------------------------------------------------------------------
    
    Jonathan G. Katz,
    Secretary.
    [FR Doc. 96-7702 Filed 3-28-96; 8:45 am]
    BILLING CODE 8010-01-M
    
    

Document Information

Published:
03/29/1996
Department:
Securities and Exchange Commission
Entry Type:
Notice
Document Number:
96-7702
Pages:
14188-14189 (2 pages)
Docket Numbers:
Release No. 34-37004, File No. SR-Phlx-95-79
PDF File:
96-7702.pdf